Ameile Patent From Hansoh Pharma Wins China Patent Gold Award
Recently, the China National Intellectual Property Administration issued its Decision on the Awarding of the 24th China Patent Award. The invention patent "EGFR Inhibitor and Preparation and Application Thereof" (Patent No.: ZL 201580045311.2) for the innovative drug Ameile (Aumolertinib Mesylate Tablets) developed by Hansoh Pharma, won the 24th China Patent Gold Award. This follows the honor that Hansoh Pharma received for the Zefei (Gemcitabine Hydrochloride for Injection) patent for which it won the China Patent Gold Award.